GSK enters into exclusive strategic vaccine partnership with Zhifei in China
The partnership will substantially enhance the accessibility of Shingrix in China, as it involves joint promotion to healthcare…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Oct 23
The partnership will substantially enhance the accessibility of Shingrix in China, as it involves joint promotion to healthcare…
10 Oct 23
Oregovomab is a murine monoclonal antibody
10 Oct 23
Strategic Financial Sponsor to Support Continued Growth and Market Expansion
09 Oct 23
Through the acquisition, BMS will add Mirati’s lung cancer drug Krazati to its commercial portfolio, along with several…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Oct 23
The Type II extension of indication application seeks approval for Rybrevant combo as a first-line treatment of NSCLC…
06 Oct 23
The acquisition will strengthen Kyowa Kirin’s portfolio with several HSC gene therapies targeting serious diseases, maximise the value…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Oct 23
Under the agreement, Biovectra will use Acuitas’ LNP technology platform on a non-exclusive basis to manufacture the mRNA-based…
06 Oct 23
The acquisition will allow Sharp to provide a comprehensive, fully integrated solution for small-to-medium-scale sterile injectable services within…
06 Oct 23
Bayer will have the option to license antibodies discovered under the collaboration
06 Oct 23
Increased capability to produce medicines for challenging diseases including cancer